Similar Items: Assessing gene expression of coagulation factors and Factor XIII polymorphisms in type 2 diabetes mellitus patients
- Peroxisome Proliferator-Activated Receptor Gamma (PPARG2) rs3856806 Gene Polymorphism as a Risk Factor for Type 2 Diabetes Mellitus
- Phase-specific dynamics of coagulation factors V, VIII, and XIII during liver transplantation: insights from a prospective study
- Inflammatory markers and ultrastructure of the coagulation profile in diabetes mellitus
- Cystatin C and Its Role in Patients with Type 1 and Type 2 Diabetes Mellitus
- The prevalence of frailty and associated factors in patients with type 2 diabetes mellitus and coronary heart disease: A cross‐sectional study
- Knowledge, adherence and quality of life among type 2 diabetes mellitus Patients
Author: Phulukdaree, Alisa
- Identifying circulating biomarkers in a cohort of hypercholesterolaemic patients with statin intolerance from Gauteng, South Africa
- The prevalence of 3-hydroxy-3-methylglutaryl-Coenzyme a reductase variants in hypercholesterolaemic patients with statin intolerance
- The association of methylglyoxal-adducts with kinetics and ultrastructure of fibrin clots in coronary artery disease patients with type 2 diabetes mellitus
- High throughput in silico screening and in vitro testing of polypharmacological bromodomain 4 and cancer associated kinase inhibitors
- Assessing gene expression of coagulation factors and Factor XIII polymorphisms in type 2 diabetes mellitus patients